Insider · CIK 0001051411

MAST ERLE T

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001051411

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-07	ZOGENIX, INC.U Disposition from Tender	Director	UDisposition from Tender	−3,027 sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,250 sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2022-03-07	ZOGENIX, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2022-02-01	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,250 sh	$12.00	+$15K	4,277
2022-02-01	ZOGENIX, INC.S Sale	Director	SSale	−1,250 sh	$26.04	−$32.5K	3,027
2022-02-01	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,250 sh	—	—	0
2022-01-19	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+6,250 sh	$15.04	+$94K	9,277
2022-01-19	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,375 sh	$14.88	+$65.1K	13,652
2022-01-19	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,375 sh	$12.00	+$52.5K	18,027
2022-01-19	ZOGENIX, INC.S Sale	Director	SSale	−15K sh	$26.09	−$391K	3,027
2022-01-19	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,250 sh	—	—	0
2022-01-19	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,375 sh	—	—	0
2022-01-19	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,375 sh	—	—	1,250
2021-05-27	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,000
2020-05-29	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2019-05-22	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2018-11-26	ZOGENIX, INC.S Sale	Director	SSale	−1,468 sh	$42.08	−$61.8K	3,027
2018-10-02	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,250 sh	$28.00	+$35K	4,277
2018-10-02	ZOGENIX, INC.M Exercise/Conversion	Director	MExercise/Conversion	+218 sh	$20.00	+$4,360	4,495
2018-10-02	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,250 sh	—	—	0
2018-10-02	ZOGENIX, INC.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−218 sh	—	—	0
2018-06-01	Sienna Biopharmaceuticals, Inc.Stock Options (Right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-05-23	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-08-01	Sienna Biopharmaceuticals, Inc.P Purchase	Director	PPurchase	+6,700 sh	$15.00	+$101K	6,700
2017-05-23	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-07-13	ZOGENIX, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−89 sh	$98.82	−$8,794.98	138,494
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−111 sh	$100.80	−$11.2K	138,383
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−100 sh	$102.67	−$10.3K	138,283
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−500 sh	$104.28	−$52.1K	137,783
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−400 sh	$105.09	−$42K	137,383
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−1,000 sh	$106.33	−$106K	136,383
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−700 sh	$107.29	−$75.1K	135,683
2015-11-02	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−100 sh	$108.16	−$10.8K	135,583
2015-10-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−900 sh	$89.40	−$80.5K	140,683
2015-10-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−1,580 sh	$90.28	−$143K	139,103
2015-10-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−420 sh	$91.30	−$38.3K	138,683
2015-10-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−100 sh	$92.09	−$9,209	138,583
2015-09-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−200 sh	$76.39	−$15.3K	144,383
2015-09-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−400 sh	$78.23	−$31.3K	143,983
2015-09-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−1,000 sh	$79.39	−$79.4K	142,983
2015-09-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−1,300 sh	$80.34	−$104K	141,683
2015-09-01	Clovis Oncology, Inc.S Sale	Executive VP and CFO	SSale	−100 sh	$81.07	−$8,107	141,583
2015-08-27	Receptos, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,400 sh	—	—	0
2015-08-27	Receptos, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.8K sh	$213.23	−$4.01M	0
2015-08-27	Receptos, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,400 sh	$204.56	−$1.92M	0
2015-08-25	Receptos, Inc.U Disposition from Tender	Director	UDisposition from Tender	−300 sh	—	—	7,400

Recent filings

Accepted (ET)
Mar 94
MAST ERLE T0000899243-22-010299
SEC(opens sec.gov)
Feb 34
MAST ERLE T0001375151-22-000006
SEC(opens sec.gov)
Jan 214
MAST ERLE T0001375151-22-000002
SEC(opens sec.gov)
May 284
MAST ERLE T0001375151-21-000062
SEC(opens sec.gov)
Jun 294
MAST ERLE T0001375151-20-000109
SEC(opens sec.gov)
May 284
MAST ERLE T0001375151-19-000080
SEC(opens sec.gov)
Nov 264
MAST ERLE T0001375151-18-000087
SEC(opens sec.gov)

Companies

Address

C/O SOMAXON PHARMACEUTICALS, INC. 3830 VALLEY CENTRE DRIVE, SUITE 705-461

SAN DIEGO, CA, 92130